HR 4825
115th Congress
House
Crime and Law Enforcement
Administrative law and regulatory procedures
Alternative treatments
Drug safety, medical device, and laboratory regulation
Drug therapy
Drug trafficking and controlled substances
Health personnel
Licensing and registrations
Medical research
Research administration and funding
MEDS Act
Introduced: January 18, 2018
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 24, 2018
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jan 19, 2018
Referred to the Subcommittee on Health.
Jan 18, 2018
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jan 18, 2018
Introduced in House
Plain-English summary
Marijuana Effective Drug Studies Act of 2018 or the MEDS Act
This bill amends the Controlled Substances Act to establish a new, separate registration process to facilitate research involving marijuana and the commercial production of drugs made from marijuana.
Specifically, the bill requires the Drug Enforcement Administration to register manufacturers and distributors to supply marijuana: (1) for use in research, and (2) for the commercial production of approved drugs containing or derived from marijuana.
What's happening now
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Committees of jurisdiction
4